BioNano Genomics Inc (BNGO) is down 3.14% Tuesday In Premarket Trading

Tuesday, January 18, 2022 08:10 AM | InvestorsObserver Analysts

Mentioned in this article

BioNano Genomics Inc (BNGO) is down Tuesday morning, with the stock declining -3.14% in pre-market trading to 2.47. BNGO's short-term technical score of 31 indicates that the stock has traded less bullishly over the last month than 69% of stocks on the market. In the Diagnostics & Research industry, which ranks 123 out of 146 industries, the stock ranks higher than 41% of stocks. BioNano Genomics Inc has fallen 25.00% over the past month, closing at $3.29 on December 21. During this period of time, the stock fell as low as $2.54 and as high as $3.48. BNGO has an average analyst recommendation of Strong Buy. The company has an average price target of $12.00.

BNGO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on BNGO!
BioNano Genomics Inc has a Long-Term Technical rank of 15. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 85% of the market scoring higher. In the Diagnostics & Research industry which is number 134 by this metric, BNGO ranks better than 36% of stocks.

Important Dates for Investors in BNGO:

-BioNano Genomics Inc is set to release earnings on 2/2/2022. During their last earnings release the company posted EPS of $-0.23. -We do not have a set dividend date for BioNano Genomics Inc at this time. Click Here To Get The Full Report on BioNano Genomics Inc (BNGO)

Share this article: